Applied Pharmaceutical Innovation

Overview

Applied Pharmaceutical Innovation (API) is described as one of Canada's largest not-for-profit life sciences commercialization organizations. It provides fee-for-service support to help pharmaceutical, biologics, medical device and diagnostics, natural health product, and health technology companies commercialize their products.

CDMO services

• Sterile fill-finish
• Oral dosage manufacturing
• Topical application manufacturing
• Natural health products
• Small molecule manufacturing
• Highly potent controlled substances

The Drug Development and Innovation Centre is cited as providing significant capacity for formulations and GMP manufacturing, along with licenses relating to cannabis and other controlled substances.

CRO services

• Research and development: scientific and technical expertise from early discovery through development
• Regulatory and quality: regulatory and quality leadership for qualification standards across development stages
• Clinical and quantitative solutions: clinical, statistical, and modeling expertise across preclinical and clinical development

Facilities

• Biotechnology Business Development Centre (BBDC): a multi-tenant accelerator for scale-ups
• Pharmaceutical Analysis Laboratory (PAL): characterization and analysis services for API
• Drug Development and Innovation Centre (DDIC): formulations, GMP capacity, and controlled substance licensing

API is headquartered in Edmonton, Alberta, with a satellite location in Calgary.